PNC Financial Services Group
NRIX icon

PNC Financial Services Group’s Nurix Therapeutics NRIX Stock Holding History

PNC Financial Services Group’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Buy
600
+150
+33% +$2.56K ﹤0.01% 3924
2026
Q1 		$6.97K Hold
450
– – ﹤0.01% 4119
2025
Q4 		$8.54K Buy
450
+10
+2% +$144 ﹤0.01% 4030
2025
Q3 		$4.07K Buy
440
+310
+238% +$3.22K ﹤0.01% 4292
2025
Q2 		$1.48K Buy
130
+76
+141% +$821 ﹤0.01% 4491
2025
Q1 		$642 Buy
54
+37
+218% +$619 ﹤0.01% 4589
2024
Q4 		$320 Hold
17
– – ﹤0.01% 4593
2024
Q3 		$382 Hold
17
– – ﹤0.01% 4599
2024
Q2 		$355 Buy
17
+13
+325% +$202 ﹤0.01% 4581
2024
Q1 		$59 Buy
+4
New +$43 ﹤0.01% 4661

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group's NRIX Position: Q2 2026 in Review

PNC Financial Services Group increased its Nurix Therapeutics (NRIX) stake by 33% in Q2 2026, buying an estimated $2.56K and bringing the position to 600 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3924.

PNC Financial Services Group first reported a position in NRIX in Q1 2024 and has held it in 10 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • PNC Financial Services Group held 600 shares of Nurix Therapeutics worth $14.6K as of Q2 2026.
  • PNC Financial Services Group bought 150 Nurix Therapeutics shares in Q2 2026, an estimated $2.56K.
  • Nurix Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3924 holding.
  • PNC Financial Services Group first reported a position in Nurix Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.